Association between FAR, PAR, APRI and adverse neonatal outcomes in pregnancies complicated by intrahepatic cholestasis
FAR and APRI levels are elevated in pregnancies with IHCP, yet FAR alone demonstrates limited predictive value for adverse neonatal outcomes. It may serve as a supportive, rather than standalone, marker. Further large-scale prospective studies are warranted.
Authors
- Neval Çayönü Kahraman (ORCID: https://orcid.org/0000-0001-8832-0081)
- Şevki Çelen (ORCID: https://orcid.org/0000-0001-7033-3474)
- Ali Turhan Çağlar (ORCID: https://orcid.org/0000-0002-7022-3029)
- Dilara Duygulu Bulan (ORCID: https://orcid.org/0000-0001-9983-2306)
- Muradiye Yıldırım (ORCID: https://orcid.org/0000-0002-6583-2153)
- Betül Tokgöz Çakır (ORCID: https://orcid.org/0000-0003-0202-4981)
- Ruken Dayanan (ORCID: https://orcid.org/0000-0002-8192-8841)
- Fulya Akın (ORCID: https://orcid.org/0009-0004-4026-1974)
Institutions
- Ministry of Health (TR)
- Sağlık Bilimleri Üniversitesi (TR)
Publication Details
- Journal
- Journal of Perinatal Medicine
- Published
- 2025-12-06
- DOI
- https://doi.org/10.1515/jpm-2025-0323
- Primary Topic
- Drug Transport and Resistance Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00